Treating Newly-Diagnosed Crohn's Patients With Advanced Therapy Leads to Dramatic Improvements in Outcomes Feb. 22, 2024 — A large-scale clinical trial of treatment strategies for Crohn's ...

The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...

"Our study suggests that vedolizumab is a viable option for induction and long-term maintenance therapy in children with IBD, ...

If you have an inflammatory bowel disease like Crohn’s or ulcerative colitis and have trouble focusing or remembering things, ...

The multicentre, prospective, cohort study by Ohad Atia and colleagues1 on the long-term efficacy and safety of maintenance vedolizumab in paediatric patients with inflammatory bowel disease (IBD) ...

French biotech moves on with the late stage drug development, after publishing impressive clinical trial results of ABX464 for treatment of colitis and hinting its potential in Crohn’s disease.

2010 Expert Reviews Ltd. Cite this: What is the Optimal Therapy for Crohn's Disease: Step-up or Top-down? - Medscape - Apr 01, 2010. The current medical treatment for Crohn's disease does not ...

UK scientists have made a major breakthrough while investigating inflammatory bowel disease, which could change the lives of ...

Crohn's disease and ulcerative colitis are idiopathic ... patients for whom the natural history of disease and response to treatment are predictable. The most widely held hypothesis on the ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

Odds of complications significantly reduced with early anti-TNFα therapy, especially in those with perianal lesions ...

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...